Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +2K | +6.86% | $0.00 | 31.2K | Feb 18, 2024 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$76.4K | -1.16K | -3.72% | $65.82 | 30K | Feb 18, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -2K | -100% | $0.00* | 0 | Feb 18, 2024 | Common Stock | 2K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock. |
F2 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. |